Not Yet Recruiting
A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast Cancer
NCT07406542
- Conditions
- Breast Diseases, Breast Neoplasms, Disease Attributes, +8 more
- Locations
-
Not specified